Stay updated on Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5. This indicates a behind-the-scenes update to the site without changing the displayed study information.
    Difference
    0.1%
    Check dated 2026-08-08T18:26:41.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.4, reflecting a software update. No clinical content or trial details were changed.
    Difference
    0.1%
    Check dated 2026-07-25T10:22:43.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.3) has been added, replacing the previous v3.6.2 to indicate a recent content update.
    Difference
    0.1%
    Check dated 2026-07-03T22:47:02.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a deployment patch. This appears to be an internal update and does not reflect changes to study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:28.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    The study page now clearly indicates that it is no longer looking for participants, clarifying that recruitment has ceased. In addition, labels for the Intervention/Treatment section were updated to remove spacing around the slash and a site revision note (v3.6.0) was added.
    Difference
    0.4%
    Check dated 2026-06-12T12:25:38.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4, signaling a page update. It reflects internal maintenance rather than changes to clinical trial details presented on the page.
    Difference
    0.1%
    Check dated 2026-06-05T08:40:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.